A new report has found that emerging companies, most with no presence in Australia, are responsible for over 90 per cent of gene, cell and nucleotide therapies currently in late-stage pipelines. …
Latest Video
New Stories
-
The COVID-19 vaccine manufacturing and supply deals
August 7, 2020 - - Latest News -
Greg Hunt moves to extend industry agreements
August 7, 2020 - - Latest News -
CSL says it is now 'exploring ways' to manufacture another vaccine
August 7, 2020 - - Latest News -
Goldman Sachs: US will be first because it has invested the most
August 6, 2020 - - Latest News -
What is the strategy? Is there a strategy?
August 6, 2020 - - Comment -
Neurohack brainstorms solutions for young people with SMA
August 6, 2020 - - Latest News -
Ventolin with dose counter makes it to the PBS
August 6, 2020 - - Latest News